DOCSLIB.ORG

Clinical Microbiology 12Th Edition

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Volume 1 Manual of Clinical Microbiology 12th Edition Downloaded from www.asmscience.org by IP: 94.66.220.5 MCM12_FM.indd 1 On: Thu, 18 Apr 2019 08:17:55 2/12/19 6:48 PM Volume 1 Manual of Clinical Microbiology 12th Edition EDITORS-IN-CHIEF Karen C. Carroll Michael A. Pfaller Division of Medical Microbiology, Departments of Pathology and Epidemiology Department of Pathology, The Johns Hopkins (Emeritus), University of Iowa, University School of Medicine, Iowa City, and JMI Laboratories, Baltimore, Maryland North Liberty, Iowa VOLUME EDITORS Marie Louise Landry Robin Patel Laboratory Medicine and Internal Medicine, Infectious Diseases Research Laboratory, Yale University, New Haven, Connecticut Mayo Clinic, Rochester, Minnesota Alexander J. McAdam Sandra S. Richter Department of Laboratory Medicine, Boston Department of Laboratory Medicine, Children’s Hospital, Boston, Massachusetts Cleveland Clinic, Cleveland, Ohio David W. Warnock Atlanta, Georgia Washington, DC Downloaded from www.asmscience.org by IP: 94.66.220.5 MCM12_FM.indd 2 On: Thu, 18 Apr 2019 08:17:55 2/12/19 6:48 PM Volume 1 Manual of Clinical Microbiology 12th Edition EDITORS-IN-CHIEF Karen C. Carroll Michael A. Pfaller Division of Medical Microbiology, Departments of Pathology and Epidemiology Department of Pathology, The Johns Hopkins (Emeritus), University of Iowa, University School of Medicine, Iowa City, and JMI Laboratories, Baltimore, Maryland North Liberty, Iowa VOLUME EDITORS Marie Louise Landry Robin Patel Laboratory Medicine and Internal Medicine, Infectious Diseases Research Laboratory, Yale University, New Haven, Connecticut Mayo Clinic, Rochester, Minnesota Alexander J. McAdam Sandra S. Richter Department of Laboratory Medicine, Boston Department of Laboratory Medicine, Children’s Hospital, Boston, Massachusetts Cleveland Clinic, Cleveland, Ohio David W. Warnock Atlanta, Georgia Washington, DC Downloaded from www.asmscience.org by IP: 94.66.220.5 MCM12_FM.indd 3 On: Thu, 18 Apr 2019 08:17:55 2/12/19 6:48 PM Copyright © 2019 American Society for Microbiology, Washington, DC ASM Press is a registered trademark of the American Society for Microbiology. All rights reserved. No part of this publication may be reproduced or transmitted in whole or in part or reutilized in any form or by any means, electronic or mechanical, including photocopying and recording, or by any information storage and retrieval system, without permission in writing from the publisher. Disclaimer: To the best of the publisher’s knowledge, this publication provides information concerning the subject matter covered that is accurate as of the date of publication. The publisher is not providing legal, medical, or other professional services. Any reference herein to any specific commercial products, procedures, or services by trade name, trademark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favored status by the American Society for Microbiology (ASM). The views and opinions of the author(s) expressed in this publication do not necessarily state or reflect those of ASM, and they shall not be used to advertise or endorse any product. Library of Congress Cataloging-in-Publication Data Names: Carroll, Karen C., editor. | Pfaller, Michael A., editor. | Landry, Marie Louise, editor. | McAdam, Alexander J., editor. | Patel, Robin, M.D., editor. | Richter, Sandra S., editor. | Warnock, D. W., editor. Title: Manual of clinical microbiology / editors in chief, Karen C. Carroll, Division of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, Michael A. Pfaller, Departments of Pathology and Epidemiology (emeritus), University of Iowa, Iowa City, and JMI Laboratories, North Liberty, Iowa ; editors, Marie Louise Landry, Laboratory Medicine and Internal Medicine, Yale University, New Haven, Connecticut, Alexander J. McAdam, Department of Laboratory Medicine, Boston Children’s Hospital, Boston, Massachusetts, Robin Patel, Infectious Diseases Research Laboratory, Mayo Clinic, Rochester, Minnesota, Sandra S. Richter, Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, David W. Warnock, Atlanta, Georgia. Description: 12th edition. | Washington, DC : ASM Press, [2019] | Includes bibliographical references and index. Identifiers: LCCN 2018057849 | ISBN 9781555819835 Subjects: LCSH: Medical microbiology—Handbooks, manuals, etc. | Diagnostic microbiology—Handbooks, manuals, etc. Classification: LCC QR46 .M425 2019 | DDC 616.9/041—dc23 LC record available at https://lccn.loc.gov/2018057849 Printed in Canada 10 9 8 7 6 5 4 3 2 1 Address editorial correspondence to: ASM Press, 1752 N St., N.W., Washington, DC 20036-2904, USA. Send orders to: ASM Press, P.O. Box 605, Herndon, VA 20172, USA. Phone: 800-546-2416; 703-661-1593. Fax: 703-661-1501. E-mail: [email protected] Online: http://estore.asm.org Downloaded from www.asmscience.org by IP: 94.66.220.5 MCM12_FM.indd 4 On: Thu, 18 Apr 2019 08:17:55 2/12/19 6:48 PM Contents 9 Prevention of Health Care-Associated Infections / 139 Volume 1 DANIEL J. DIEKEMA AND MICHAEL A. PFALLER 10 Investigation of Disease Outbreaks / 155 Editorial Board xi IONA MUNJAL, WENDY A. SZYMCZAK, AND Contributors xiii BELINDA OSTROWSKY 11 Molecular Epidemiology / 167 Preface xxv EIJA TREES, TERRY FEI FAN NG, Author and Editor Conflicts of Interest xxvi DUNCAN MacCANNELL, PAUL A. ROTA, AND PETER GERNER-SMIDT 12 Procedures for the Storage of Microorganisms / 197 ROSEMARY C. SHE AND SUSAN M. BUTLER-WU section I 13 Prevention of Laboratory-Acquired Diagnostic Strategies and Infections / 206 PHILIPPE LAGACÉ-WIENS AND General Topics / 1 MICHAEL PENTELLA VOLUME EDITOR: SANDRA S. RICHTER 14 Disinfection and Sterilization / 224 SECTION EDITOR: JAMES KARLOWSKY MATTHEW J. ARDUINO AND GERALD McDONNELL 1 Introduction to the 12th Edition of the Manual of Clinical Microbiology / 3 15 Biothreat Agents / 243 KAREN C. CARROLL AND MICHAEL A. PFALLER JAMES W. SNYDER, STEVEN D. MAHLEN, SUSAN E. SHARP, AND MICHAEL LOEFFELHOLZ 2 Laboratory Accreditation and Compliance / 5 16 The Human Microbiome / 254 MICHAEL LOEFFELHOLZ, LINOJ SAMUEL, AND SUSAN SHARP JAMES VERSALOVIC, SARAH K. HIGHLANDER, BHANU P. GANESH, AND JOSEPH F. PETROSINO 3 Microscopy / 16 17 Microbial Genomics and Pathogen Discovery / 269 STEVEN D. DALLAS JENNIFER K. SPINLER AND JAMES VERSALOVIC 4 Laboratory Detection of Bacteremia and Fungemia / 28 MICHAEL L. WILSON, MELVIN P. WEINSTEIN, AND L. BARTH RELLER section 5 Systems for Identification of Bacteria and Fungi / 45 II KAREN C. CARROLL AND ROBIN PATEL Bacteriology / 284 6 Automation and Design of the Clinical Microbiology Laboratory / 72 VOLUME EDITORS: ROBIN PATEL AND ALEXANDER J. McADAM CHRISTOPHER D. DOERN AND MARTIN HOLFELDER SECTION EDITORS: CAREY-ANN BURNHAM, J. STEPHEN DUMLER, MELISSA B. MILLER, 7 Molecular Microbiology / 86 ELISABETH NAGY, AND JOHANN PITOUT FREDERICK S. NOLTE 8 Immunoassays for the Diagnosis of Infectious General Diseases / 124 18 Taxonomy of Bacteria and Archaea / 287 ELITZA S. THEEL PAUL A. LAWSON AND KERIN L. TYRRELL v Downloaded from www.asmscience.org by IP: 94.66.220.5 MCM12_FM.indd 5 On: Thu, 18 Apr 2019 08:17:55 2/12/19 6:48 PM vi n CONTENTS 19 Specimen Collection, Transport, and Processing: 33 Mycobacterium: Laboratory Characteristics Bacteriology / 302 of Slowly Growing Mycobacteria Other than ERIN McELVANIA AND KAMALJIT SINGH Mycobacterium tuberculosis / 595 20 Reagents, Stains, and Media: ADAM J. CAULFIELD, ELVIRA RICHTER, Bacteriology / 331 BARBARA A. BROWN-ELLIOTT, RICHARD J. WALLACE, JR., AND NANCY L. WENGENACK RONALD ATLAS AND JAMES SNYDER 34 Mycobacterium: Clinical and Laboratory Characteristics of Rapidly Growing Gram-Positive Cocci Mycobacteria / 612 21 General Approaches to Identification of BARBARA A. BROWN-ELLIOTT AND Aerobic Gram-Positive Cocci / 362 RICHARD J. WALLACE, JR. JENS JØRGEN CHRISTENSEN, XIAOHUI CHEN NIELSEN, AND KATHRYN L. RUOFF Gram-Negative Bacteria Staphylococcus Micrococcus 22 , , and Other 35 Approaches to the Identification of Aerobic Catalase-Positive Cocci / 367 Gram-Negative Bacteria / 630 KARSTEN BECKER, ROBERT L. SKOV, AND NIELS NØRSKOV-LAURITSEN AND CHRISTOF von EIFF WINNIE RIDDERBERG Streptococcus 23 / 399 36 Neisseria / 640 BARBARA SPELLERBERG, CLAUDIA BRANDT, JOHANNES ELIAS, MATTHIAS FROSCH, AND AND PARHAM SENDI ULRICH VOGEL Enterococcus 24 / 418 37 Aggregatibacter, Capnocytophaga, Eikenella, LÚCIA MARTINS TEIXEIRA, MARIA DA GLÓRIA Kingella, Pasteurella, and Other Fastidious or SIQUEIRA CARVALHO, RICHARD R. FACKLAM, Rarely Encountered Gram-Negative Rods / 656 AND PATRICIA LYNN SHEWMAKER REINHARD ZBINDEN 25 Aerococcus, Abiotrophia, and Other Aerobic Catalase-Negative, Gram-Positive 38 Haemophilus / 670 Cocci / 436 MARK D. GONZALEZ AND NATHAN A. LEDEBOER JENS JØRGEN CHRISTENSEN, XIAOHUI CHEN NIELSEN, AND KATHRYN L. RUOFF 39 Escherichia, Shigella, and Salmonella / 688 BLAKE W. BUCHAN, MATTHEW L. FARON, ROMNEY M. HUMPHRIES, JOHN DEKKER, AND Gram-Positive Rods NATHAN A. LEDEBOER 26 General Approaches to the Identification of 40 Klebsiella and Selected Enterobacterales / 724 Aerobic Gram-Positive Rods / 451 STEPHEN J. FORSYTHE, JOHANN PITOUT, KATHRYN A. BERNARD ANGELLA CHARNOT-KATSIKAS, KEVIN ALBY, 27 Bacillus and Other Aerobic Endospore-Forming AND KAREN M. FRANK Bacteria / 455 41 Yersinia / 751 CHRISTINE Y. TURENNE AND LUKE C. KINGRY, CHERYL L. TARR, AND DAVID C. ALEXANDER JEANNINE M. PETERSEN 28 Listeria and Erysipelothrix / 477 42 Aeromonas / 765 NELE WELLINGHAUSEN BRIGITTE LAMY AND AMY J. HORNEMAN
Recommended publications
  • Isbn 978-625-409-353-1

    Isbn 978-625-409-353-1

    ISBN 978-625-409-353-1 INTERNATIONAL CONGRESS ON BIOLOGICAL AND HEALTH SCIENCES PROCEEDİNGS BOOK This work is subject to copyright and all rights reserved, whether the whole or part of the material is concerned. The right to publish this book belongs to International Congress on Biological and Health Sciences-2021. No part of this publication may be translated, reproduced, stored in a computerized system, or transmitted in any form or by any means, including, but not limited to electronic, mechanical, photocopying, recording without written permission from the publisher. This Proceedings Book has been published as an electronic publication (e-book). The publisher is not responsible for possible damages, which may be a result of content derived from this electronic publication All authors are responsible for the contents of their abstracts. https://www.biohealthcongress.com/ ([email protected]) Editor Ulaş ACARÖZ Published: 28/03/2021 ISBN: Editor's Note The first ‘International Congress on Biological and Health Sciences’ was organized online and free of charge. We are very happy and proud that various health science-related fields attended the congress. By this event, the distinguished and respected scientists came together to exchange ideas, develop and implement new researches and joint projects. There were 15 invited speakers from 10 different countries and also approximately 400 submissions were accepted from more than 20 countries. We would like to thank all participants and supporters. Hope to see you at our next congress.
  • An Evaluation of 2.0 Mcfarland Etest Method for Detection of Heterogeneous Vancomycin-Intermediate Staphylococcus Aureus

    An Evaluation of 2.0 Mcfarland Etest Method for Detection of Heterogeneous Vancomycin-Intermediate Staphylococcus Aureus

    10.2478/abm-2010-0016 Asian Biomedicine Vol. 4 No. 1 February 2010; 141-145 Brief communication (Original) An evaluation of 2.0 McFarland Etest method for detection of heterogeneous vancomycin-intermediate Staphylococcus aureus Montri Pongkumpaia, Suwanna Trakulsomboonb, Chusana Suankrataya aDivision of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330; bDivision of Infectious Disease and Tropical Medicine, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand Background: Staphylococcus aureus with reduced susceptibility to vancomycin or heterogeneous vancomycin- intermediate S. aureus (hVISA) have become increasingly reported from various parts of the world. hVISA cannot be detected by routine test for minimal inhibitory concentration (MIC) for vancomycin. The gold standard method for detection, population analysis profiles (PAP) method, is complicated, time-consuming, expensive, and needs well-trained microbiologists. Objective: Evaluate of 2.0 McFarland Etest method, in comparison with the PAP method, for detection of hVISA in clinical specimens. Methods: All methicillin-resistant S. aureus strains from clinical specimens isolated from consecutive patients attended at King Chulalongkorn Memorial Hospital and Siriraj Hospital, Bangkok between 2006 and 2007 were studied. 1 hundred nineteen specimens were obtained. The PAP method detected six hVISA strains 5 from blood and from cultures) from four patients at King Chulalongkorn Memorial Hospital, accounting for a prevalence of 6.35%. The MIC determined by agar dilution method was in the range of 2-3 μg/mL. Results: 2.0 McFarland Etest method detected no false positive and five false negatives (42%), and gave a sensitivity and a specificity of 16.7% and 100%, respectively.
  • The Resurgence of Mucormycosis in the Covid-19 Era – a Review

    The Resurgence of Mucormycosis in the Covid-19 Era – a Review

    ISSN: 2687-8410 DOI: 10.33552/ACCS.2021.03.000551 Archives of Clinical Case Studies Mini Review Copyright © All rights are reserved by Kratika Mishra The Resurgence of Mucormycosis in the Covid-19 Era – A Review Amit Bhardwaj1, Kratika Mishra2*, Shivani Bhardwaj3, Anuj Bhardwaj4 1Department of Orthodontics and Dentofacial Orthopaedics, Modern Dental College and Research Centre, Indore, India 2Department of Orthodontics and Dentofacial Orthopaedics, Index Institute of Dental Sciences, Indore, Madhya Pradesh, India 3Department of Prosthodontics, College of Dental Sciences, Rau, Madhya Pradesh, India 4Department of Conservative Dentistry and Endodontics, College of Dental Sciences, India *Corresponding author: Received Date: June 7, 2021 Kratika Mishra, Department of Orthodontics and Published Date: June 25, 2021 Dentofacial Orthopaedics, Index Institute of Dental Sciences, Indore, Madhya Pradesh, India. Abstract Mucormycosis (MCM) is a life-threatening infection that carries high mortality rates with devastating disease symptoms and diverse clinical manifestations. This article briefly explains clinical manifestations and risk factors and focuses on putative virulence traits associated with mucormycosis, mainly in the group of diabetic ketoacidotic patients, immunocompromised patients. The diagnosis requires the combination of various clinical data and the isolation in culture of the fungus from clinical samples. Treatment of mucormycosis requires a rapid diagnosis, correction of predisposing factors, surgical resection, debridement and
  • Bacterial Profile of Urinary Tract Infection and Antimicrobial

    Bacterial Profile of Urinary Tract Infection and Antimicrobial

    Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Year: 2016 Volume: 12 Therapeutics and Clinical Risk Management Dovepress Running head verso: Derese et al Running head recto: Bacterial profile of UTI and antimicrobial susceptibility pattern open access to scientific and medical research DOI: 99831 Open Access Full Text Article ORIGINAL RESEARCH Bacterial profile of urinary tract infection and antimicrobial susceptibility pattern among pregnant women attending at Antenatal Clinic in Dil Chora Referral Hospital, Dire Dawa, Eastern Ethiopia Behailu Derese1 Purpose: The aim of this study was to determine the bacterial profile of urinary tract infection Haji Kedir2 (UTI) and antimicrobial susceptibility pattern among pregnant women attending at antenatal Zelalem Teklemariam3 clinic in Dil Chora Referral Hospital, Dire Dawa, Eastern Ethiopia. Fitsum Weldegebreal3 Patients and methods: An institutional-based cross-sectional study was conducted from Senthilkumar Balakrishnan4 February 18, 2015 to March 25, 2015. Clean-catch midstream urine specimens were collected from 186 pregnant women using sterile containers. Then, culture and antimicrobial susceptibility 1Department of Medical Laboratory, tests were performed by standard disk diffusion method. Patient information was obtained using Dil Chora Referral Hospital, Dire Dawa, 2Department of Public Health, pretested structured questionnaire. Data were entered and cleaned using EpiData Version 3 and 3Department of Medical Laboratory then exported to Statistical Package for Social Science (Version 16) for further analysis. Sciences, 4Department of Medical Microbiology, College of Health Results: The prevalence of significant bacteriuria was 14%. Gram-negative bacteria were and Medical Sciences, Haramaya more prevalent (73%). Escherichia coli (34.6%), coagulase-negative staphylococci (19.2%), University, Harar, Ethiopia Pseudomonas aeruginosa (15.4%), and Klebsiella spp.
  • Examining the Antimicrobial Activity of Cefepime-Taniborbactam

    Examining the Antimicrobial Activity of Cefepime-Taniborbactam

    Examining the antimicrobial activity of cefepime-taniborbactam (formerly cefepime/VNRX-5133) against Burkholderia species isolated from cystic fibrosis patients in the United States Elise T. Zeiser1, Scott A. Becka1, John J. LiPuma2, David A. Six 3, Greg Moeck 3, and Krisztina M. Papp-Wallace1,4 1Veterans Affairs Northeast Ohio Healthcare System, Cleveland, OH; 2University of Michigan, Ann Arbor, MI; 3Venatorx 4 Pharmaceuticals, Inc., Malvern, PA; and Case Western Reserve University, Cleveland, OH Correspondence to: [email protected] Abstract Results Background: Burkholderia cepacia complex (Bcc), a group of >20 related species, and B. gladioli are 60 opportunistic human pathogens that cause chronic infections in people with cystic fibrosis (CF) or cefepime compromised immune systems. Ceftazidime and trimethoprim-sulfamethoxazole are first-line agents used to treat infections due to Burkholderia spp. However, these species have developed resistance to cefepime-taniborbactam many antibiotics, including first-line therapies. β-lactam resistance in Burkholderia species is largely 40 mediated by PenA-like chromosomal class A β-lactamases. A novel investigational β-lactam/β-lactamase inhibitor combination, cefepime-taniborbactam (formerly cefepime/VNRX-5133) demonstrates potent antimicrobial activity against gram-negative bacteria producing class A, B, C, and D β-lactamases. The activity of cefepime-taniborbactam was investigated against Bcc and B. gladioli; moreover, the biochemical activity of taniborbactam against the PenA1 carbapenemase was evaluated. 20 Methods: CLSI-based agar dilution antimicrobial susceptibility testing using cefepime and cefepime combined with taniborbactam at 4 mg/L was conducted against a curated panel of 150 Burkholderia species obtained from the Burkholderia cepacia Research Laboratory and Repository. Isolates were Number isolates of recovered from respiratory specimens from 150 different individuals with CF receiving care in 68 cities 0 throughout 36 states within the United States.
  • (IQC) Antimicrobial Susceptibility Tests Using Disk Diffusion

    (IQC) Antimicrobial Susceptibility Tests Using Disk Diffusion

    Internal Quality Control (IQC) Antimicrobial Susceptibility Tests Using Disk Diffusion National AMR Surveillance Network, NCDC National Programme on Containment of Antimicrobial Resistance National Centre for Disease Control, New Delhi April 2019 CONTENTS I. Scope .......................................................................................................................................................... 2 II. Selection of Strains for Quality Control ..................................................................................................... 2 III. Maintenance and Testing of QC Strains..................................................................................................... 3 Figure 1: Flow Chart: Maintenance of QC strains in a bacteriology lab......................................................... 4 IV. Quality Control (QC) Results—Documentation - Zone Diameter ............................................................. 5 V. QC Conversion Plan ................................................................................................................................... 5 1. The 20- or 30-Day Plan .......................................................................................................................... 5 2. The 15-Replicate (3× 5 Day) Plan ......................................................................................................... 5 3. Implementing Weekly Quality Control Testing ..................................................................................... 6 4.
  • <I>Mucorales</I>

    <I>Mucorales</I>

    Persoonia 30, 2013: 57–76 www.ingentaconnect.com/content/nhn/pimj RESEARCH ARTICLE http://dx.doi.org/10.3767/003158513X666259 The family structure of the Mucorales: a synoptic revision based on comprehensive multigene-genealogies K. Hoffmann1,2, J. Pawłowska3, G. Walther1,2,4, M. Wrzosek3, G.S. de Hoog4, G.L. Benny5*, P.M. Kirk6*, K. Voigt1,2* Key words Abstract The Mucorales (Mucoromycotina) are one of the most ancient groups of fungi comprising ubiquitous, mostly saprotrophic organisms. The first comprehensive molecular studies 11 yr ago revealed the traditional Mucorales classification scheme, mainly based on morphology, as highly artificial. Since then only single clades have been families investigated in detail but a robust classification of the higher levels based on DNA data has not been published phylogeny yet. Therefore we provide a classification based on a phylogenetic analysis of four molecular markers including the large and the small subunit of the ribosomal DNA, the partial actin gene and the partial gene for the translation elongation factor 1-alpha. The dataset comprises 201 isolates in 103 species and represents about one half of the currently accepted species in this order. Previous family concepts are reviewed and the family structure inferred from the multilocus phylogeny is introduced and discussed. Main differences between the current classification and preceding concepts affects the existing families Lichtheimiaceae and Cunninghamellaceae, as well as the genera Backusella and Lentamyces which recently obtained the status of families along with the Rhizopodaceae comprising Rhizopus, Sporodiniella and Syzygites. Compensatory base change analyses in the Lichtheimiaceae confirmed the lower level classification of Lichtheimia and Rhizomucor while genera such as Circinella or Syncephalastrum completely lacked compensatory base changes.
  • Table S4. Phylogenetic Distribution of Bacterial and Archaea Genomes in Groups A, B, C, D, and X

    Table S4. Phylogenetic Distribution of Bacterial and Archaea Genomes in Groups A, B, C, D, and X

    Table S4. Phylogenetic distribution of bacterial and archaea genomes in groups A, B, C, D, and X. Group A a: Total number of genomes in the taxon b: Number of group A genomes in the taxon c: Percentage of group A genomes in the taxon a b c cellular organisms 5007 2974 59.4 |__ Bacteria 4769 2935 61.5 | |__ Proteobacteria 1854 1570 84.7 | | |__ Gammaproteobacteria 711 631 88.7 | | | |__ Enterobacterales 112 97 86.6 | | | | |__ Enterobacteriaceae 41 32 78.0 | | | | | |__ unclassified Enterobacteriaceae 13 7 53.8 | | | | |__ Erwiniaceae 30 28 93.3 | | | | | |__ Erwinia 10 10 100.0 | | | | | |__ Buchnera 8 8 100.0 | | | | | | |__ Buchnera aphidicola 8 8 100.0 | | | | | |__ Pantoea 8 8 100.0 | | | | |__ Yersiniaceae 14 14 100.0 | | | | | |__ Serratia 8 8 100.0 | | | | |__ Morganellaceae 13 10 76.9 | | | | |__ Pectobacteriaceae 8 8 100.0 | | | |__ Alteromonadales 94 94 100.0 | | | | |__ Alteromonadaceae 34 34 100.0 | | | | | |__ Marinobacter 12 12 100.0 | | | | |__ Shewanellaceae 17 17 100.0 | | | | | |__ Shewanella 17 17 100.0 | | | | |__ Pseudoalteromonadaceae 16 16 100.0 | | | | | |__ Pseudoalteromonas 15 15 100.0 | | | | |__ Idiomarinaceae 9 9 100.0 | | | | | |__ Idiomarina 9 9 100.0 | | | | |__ Colwelliaceae 6 6 100.0 | | | |__ Pseudomonadales 81 81 100.0 | | | | |__ Moraxellaceae 41 41 100.0 | | | | | |__ Acinetobacter 25 25 100.0 | | | | | |__ Psychrobacter 8 8 100.0 | | | | | |__ Moraxella 6 6 100.0 | | | | |__ Pseudomonadaceae 40 40 100.0 | | | | | |__ Pseudomonas 38 38 100.0 | | | |__ Oceanospirillales 73 72 98.6 | | | | |__ Oceanospirillaceae
  • Molecular Identification of Fungi

    Molecular Identification of Fungi

    Molecular Identification of Fungi Youssuf Gherbawy l Kerstin Voigt Editors Molecular Identification of Fungi Editors Prof. Dr. Youssuf Gherbawy Dr. Kerstin Voigt South Valley University University of Jena Faculty of Science School of Biology and Pharmacy Department of Botany Institute of Microbiology 83523 Qena, Egypt Neugasse 25 [email protected] 07743 Jena, Germany [email protected] ISBN 978-3-642-05041-1 e-ISBN 978-3-642-05042-8 DOI 10.1007/978-3-642-05042-8 Springer Heidelberg Dordrecht London New York Library of Congress Control Number: 2009938949 # Springer-Verlag Berlin Heidelberg 2010 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Cover design: WMXDesign GmbH, Heidelberg, Germany, kindly supported by ‘leopardy.com’ Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) Dedicated to Prof. Lajos Ferenczy (1930–2004) microbiologist, mycologist and member of the Hungarian Academy of Sciences, one of the most outstanding Hungarian biologists of the twentieth century Preface Fungi comprise a vast variety of microorganisms and are numerically among the most abundant eukaryotes on Earth’s biosphere.
  • Culture Media Edition for Industrial Microbiology LABORATORIOS CONDA S.A

    Culture Media Edition for Industrial Microbiology LABORATORIOS CONDA S.A

    2nd Edition for Industrial Microbiology Culture Media LABORATORIOS CONDA S.A. Edited by: Laboratorios Conda S.A. © 2013. Conda S.A. All rights reserved. Printed in Spain C/ La Forja, 9 28850 - Torrejón de Ardoz, Madrid - SPAIN Tel. +34 91 761 02 00 Fax +34 91 656 82 28 C/ Berlín, 63 08029 Barcelona - SPAIN Tel. +34 93 363 72 64 / 65 Fax. +34 93 363 72 61 [email protected] [email protected] www.condalab.com Index 6 Meat & Fish Industry 20 Beer Industry 10 Water & Beverages 21 Waste Water 11 Dairy Products 23 Cosmetic Industry 15 Bakery 24 Pharmaceutical Industry 17 Processed Foods 25 Microbiology Dehydrated Culture Media Guide 19 Wines iv Media for Industrial Microbiology CULTURE MEDIA FOR INDUSTRIAL MICROBIOLOGY | 2ND EDITION Media for Industrial Microbiology 5 Culture Media for Industrial Microbiology Laboratorios CONDA, one of the world USP and AOAC standards. Strict quality leaders in the design and manufacturing of control procedures are adopted prior to, high quality culture media, currently offers during and after the manufacturing process more than 400 different products, among to ensure quality products and batch-to-batch which you will find chromogenic media, ISO- consistency. We also exert tight control over formulated media and custom-made media selection and treatment of all raw materials for many different industrial applications. and components (peptones, carbohydrates, minerals, chemicals, agar and other additives) From hygiene control, through food used in the manufacturing process. Physical- and beverage poisoning prevention, to chemical characteristics are tested, and microbiologial examination of cosmetic and media also undergo additional microbiological pharmaceutical products, CONDA supplies a tests that guarantee growth, differentiation, wide variety of different media for each field biochemical performance, recovery of small so that customers can find the most suitable inocula, selectivity, etc.
  • Pocket Guide to Clinical Microbiology

    Pocket Guide to Clinical Microbiology

    4TH EDITION Pocket Guide to Clinical Microbiology Christopher D. Doern 4TH EDITION POCKET GUIDE TO Clinical Microbiology 4TH EDITION POCKET GUIDE TO Clinical Microbiology Christopher D. Doern, PhD, D(ABMM) Assistant Professor, Pathology Director of Clinical Microbiology Virginia Commonwealth University Health System Medical College of Virginia Campus Washington, DC Copyright © 2018 Amer i can Society for Microbiology. All rights re served. No part of this publi ca tion may be re pro duced or trans mit ted in whole or in part or re used in any form or by any means, elec tronic or me chan i cal, in clud ing pho to copy ing and re cord ing, or by any in for ma tion stor age and re trieval sys tem, with out per mis sion in writ ing from the pub lish er. Disclaimer: To the best of the pub lish er’s knowl edge, this pub li ca tion pro­ vi des in for ma tion con cern ing the sub ject mat ter cov ered that is ac cu rate as of the date of pub li ca tion. The pub lisher is not pro vid ing le gal, med i cal, or other pro fes sional ser vices. Any ref er ence herein to any spe cific com mer cial prod ucts, pro ce dures, or ser vices by trade name, trade mark, man u fac turer, or oth er wise does not con sti tute or im ply en dorse ment, rec om men da tion, or fa vored sta tus by the Ameri can Society for Microbiology (ASM).
  • Aliarcobacter Butzleri from Water Poultry: Insights Into Antimicrobial Resistance, Virulence and Heavy Metal Resistance

    Aliarcobacter Butzleri from Water Poultry: Insights Into Antimicrobial Resistance, Virulence and Heavy Metal Resistance

    G C A T T A C G G C A T genes Article Aliarcobacter butzleri from Water Poultry: Insights into Antimicrobial Resistance, Virulence and Heavy Metal Resistance Eva Müller, Mostafa Y. Abdel-Glil * , Helmut Hotzel, Ingrid Hänel and Herbert Tomaso Institute of Bacterial Infections and Zoonoses (IBIZ), Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, 07743 Jena, Germany; Eva.Mueller@fli.de (E.M.); Helmut.Hotzel@fli.de (H.H.); [email protected] (I.H.); Herbert.Tomaso@fli.de (H.T.) * Correspondence: Mostafa.AbdelGlil@fli.de Received: 28 July 2020; Accepted: 16 September 2020; Published: 21 September 2020 Abstract: Aliarcobacter butzleri is the most prevalent Aliarcobacter species and has been isolated from a wide variety of sources. This species is an emerging foodborne and zoonotic pathogen because the bacteria can be transmitted by contaminated food or water and can cause acute enteritis in humans. Currently, there is no database to identify antimicrobial/heavy metal resistance and virulence-associated genes specific for A. butzleri. The aim of this study was to investigate the antimicrobial susceptibility and resistance profile of two A. butzleri isolates from Muscovy ducks (Cairina moschata) reared on a water poultry farm in Thuringia, Germany, and to create a database to fill this capability gap. The taxonomic classification revealed that the isolates belong to the Aliarcobacter gen. nov. as A. butzleri comb. nov. The antibiotic susceptibility was determined using the gradient strip method. While one of the isolates was resistant to five antibiotics, the other isolate was resistant to only two antibiotics. The presence of antimicrobial/heavy metal resistance genes and virulence determinants was determined using two custom-made databases.